Control of risk factors in and treatment of patients with coronary heart disease: The TRECE study;Control de los factores de riesgo y tratamiento de los pacientes con cardiopatía isquémica: registro TRECE

Revista Espanola de Cardiologia

Volumn 62, Issue 7, 2009, Pages 807-811

  Bertomeu, Vicente ^a   Cordero, Alberto ^a   Quiles, Juan ^a   Mazón, Pilar ^b   Aznar, Joaquín ^c   Bueno, Héctor ^d  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^b Hospital Santiago de Compostela   (Spain)

^c Hospital Nuestra Senora de Gracia   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Coronary heart disease; Limitations; Optimal medical treatment

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ABDOMINAL OBESITY; AGED; ANGINA PECTORIS; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; PRESCRIPTION; PRIMARY MEDICAL CARE; REVASCULARIZATION; UNSTABLE ANGINA PECTORIS;

AGED; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; RISK FACTORS;

EID: 67849111424     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)71694-X     Document Type: Article

References (15)

1. M. Heras, J. Marrugat, F. Aros, X. Bosch, J. Enero, and M.A. Suarez Reducción de la mortalidad por infarto agudo de miocardio en un periodo de 5 años Rev Esp Cardiol 59 2006 200 208
2. W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, and N. Haase Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 117 2008 e25 e146
3. C. Daly, F. Clemens, J.L. Lopez-Sendon, L. Tavazzi, E. Boersma, and N. Danchin The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina Eur Heart J 27 2006 1298 1304
4. W.E. Boden, R.A. O'Rourke, K.K. Teo, P.M. Hartigan, D.J. Maron, and W.J. Kostuk Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
5. T.D. Fraker Jr, S.D. Fihn, R.J. Gibbons, J. Abrams, K. Chatterjee, and J. Daley 2007 Chronic Angina Focused Updated of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to Develop the Focused Update of the 2002 Guidelines for the Management of Patients With Chronic Stable Angina Circulation 116 2007 2762 2772
6. European 2003 Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-53.
7. A. Diaz, M.G. Bourassa, M.C. Guertin, and J.C. Tardif Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease Eur Heart J 26 2005 967 974
8. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
9. L. Ryden, E. Standl, M. Bartnik, B.G. Van den, J. Betteridge, and M.J. De Boer Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur Heart J 28 2007 88 136
10. M. Sachdev, J.L. Sun, A.A. Tsiatis, C.L. Nelson, D.B. Mark, and J.G. Jollis The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease J Am Coll Cardiol 43 2004 576 582
11. D.L. Bhatt, P.G. Steg, E.M. Ohman, A.T. Hirsch, Y. Ikeda, and J.L. Mas International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis JAMA 295 2006 180 189
12. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet. 2001;357:995-1001.
13. J.R. Gonzalez-Juanatey, E. Alegria-Ezquerra, J. Aznar-Costa, V. Bertomeu-Martinez, J. Franch-Nadal, and J.L. Palma-Gamiz Conocimiento y aplicación de las guías de práctica clínica sobre riesgo cardiovascular en las consultas generales y especializadas Rev Esp Cardiol 59 2006 801 806
14. J. Lopez-Sendon, K. Swedberg, J. McMurray, J. Tamargo, A.P. Maggioni, and H. Dargie Documento de Consenso de Expertos sobre bloqueadores de los receptores ß-adrenérgicos Rev Esp Cardiol 58 2005 65 90
15. L. Lopez-Bescos, S. Filipova, and R. Martos Long-term safety and efficacy of ivabradine in patients with chronic stable angina Cardiology 108 2007 387 396